Period12 Jan 2022

Media coverage

7

Media coverage

  • TitlePharmaMar confirms in vitro activity of plitidepsin against Delta and Omicron; Publishes data in The Life Science Alliance journal
    Media name/outletM2Pharma.com
    Country/TerritoryUnited States
    Date12/01/22
    URLm2pharma.com/news/policy-and-regulations/article.php?id=95895
    PersonsAdolfo Garcia-Sastre
  • TitlePharmaMar confirms in vitro activity of plitidepsin against Delta and Omicron; Publishes data in The Life Science Alliance journal
    Media name/outletCorporate IT Update
    Country/TerritoryUnited States
    Date12/01/22
    PersonsAdolfo Garcia-Sastre
  • TitlePharmaMar confirms in vitro activity of plitidepsin against Delta and Omicron; Publishes data in The Life Science Alliance journal
    Media name/outletM2 Pharma
    Country/TerritoryUnited States
    Date12/01/22
    PersonsAdolfo Garcia-Sastre
  • TitleLife Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants
    Media name/outletMarketScreener.com
    Country/TerritoryUnited States
    Date12/01/22
    URLhttps://www.marketscreener.com/quote/stock/PHARMA-MAR-S-A-24798227/news/Life-Science-Alliance-journal-publishes-results-of-plitidepsin-in-patients-with-COVID-19-which-incl-37529858/
    PersonsAdolfo Garcia-Sastre
  • TitlePharmaMar confirms in vitro activity of plitidepsin against Delta and Omicron; Publishes data in The Life Science Alliance journal
    Media name/outletFinancialWire
    Country/TerritoryAustralia
    Date12/01/22
    PersonsAdolfo Garcia-Sastre
  • TitlePharmaMar confirms in vitro activity of plitidepsin against Delta and Omicron; Publishes data in The Life Science Alliance journal
    Media name/outletM2 EquityBites
    Country/TerritoryUnited Kingdom
    Date12/01/22
    PersonsAdolfo Garcia-Sastre
  • Title-Life Science Alliance journal publishes results of plitidepsin in patients with COVID-19, which includes additional data on its antiviral activity against Delta and Omicron variants
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date12/01/22
    PersonsAdolfo Garcia-Sastre